Analysis of Emergency Department Visits According to Incidence of Covid-19

November 19, 2021 updated by: Centre Hospitalier de Roubaix

Analysis of Emergency Department Visits According to Incidence of Covid-19 in French Metropolis : a One-year Multicenter Observational Retrospective Study.

With lockdown, Emergency Departments (ED) visits decrease, principally for visits unrelated with Covid-19. In this study, the investigators aimed to find a correlation between ED visits and incidence rate of Covid-19 in a French metropolis.

Study Overview

Status

Completed

Conditions

Detailed Description

All patients older than 18 years were included in 9 ED during 51 weeks. Patients transferred between the centers participating in the study were excluded.

The investigators count the number of visits per weeks, then the number of visits according to :

  • reason for consultation Covid-like (cough, fever or dyspnea),
  • reason for consultation with accordance to French Emergency Medicine Society (SFMU) reference
  • diagnosis with accordance to SFMU reference
  • orientation (home, medical unit, chirurgical unit, intensive care unit, psychiatric unit, death)

Pearson's correlation test compare incidence rate per week with this counts and admission rate.

Study Type

Observational

Enrollment (Actual)

400000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Lille, France
        • Emergency Department, GHICL Saint-Vincent
    • Nord
      • Armentières, Nord, France
        • Emergency Department, General Hospital
      • Hazebrouck, Nord, France
        • Emergency Department, General Hospital
      • Lille, Nord, France, 59000
        • Emergency Department, University Hospital
      • Lomme, Nord, France
        • Emergency Department, GHICL Saint-Philibert
      • Roubaix, Nord, France, 59100
        • Emergency Department, General Hospital
      • Seclin, Nord, France
        • Emergency Department, General Hospital
      • Tourcoing, Nord, France
        • Emergency Department, General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All patients visited one of 9 emergency department.

Description

Inclusion Criteria:

  • patients over 18 years old

Exclusion Criteria:

  • patient who are transferred between centers participating to the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
non-Covid-19 visit
Time Frame: 51 weeks
Count of non-Covid-19 visit per week
51 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reason for visits
Time Frame: 51 weeks
Count of each reason for visits category according to SFMU reference
51 weeks
Admission rate
Time Frame: 51 weeks
Admission rate per week
51 weeks
Diagnosis
Time Frame: 51 weeks
Count of each diagnostic category according to SFMU reference
51 weeks
Orientation
Time Frame: 51 weeks
Count of each orientation (home, medical unit, chirurgical unit, intensive care unit, death, psychiatric unit, other)
51 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence rate of Covid 19
Time Frame: 51 weeks
Incidence rate of Covid 19 per week
51 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier de Roubaix

Collaborators

University Hospital, Lille

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 13, 2020

Primary Completion (Actual)

May 4, 2021

Study Completion (Actual)

May 4, 2021

Study Registration Dates

First Submitted

November 17, 2021

First Submitted That Met QC Criteria

November 17, 2021

First Posted (Actual)

November 19, 2021

Study Record Updates

Last Update Posted (Actual)

November 23, 2021

Last Update Submitted That Met QC Criteria

November 19, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2021-004
  • 4714175 (Other Identifier: CESREES)
  • 921296 (Other Identifier: CNIL)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergency Service, Hospital

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe